Anticonvulsant profile of nardostachys jatamansi roots in albino rats

Purushotham K., Basavanna PL


Background: Epilepsy is a common neurological disorder. Despite the massive scale of the problem and much research, epilepsy remains poorly understood. Most of the currently used antiepileptic drugs have some neurotoxic effects, cognitive deficits and teratogenic effects, which decrease their clinical utility and up to 30% of patients are still refractory to treatment. The present study is undertaken to evaluate the anticonvulsant activity of ethanolic extract of nardostachys jatamansi root in albino rats.

Methods: Albino rats (150-200 gms) of male sex were randomly selected, from central animal facility. They were divided into 5groups(per model) of 6 rats each, control group-propylene glycol 0.5 ml, standard group-sodium valproate (300 mg/kg), dose 1-ethanolic extract of nardostachys jatamansi roots (100 mg/kg), dose 2-ethanolic extract of nardostachys jatamansi roots (200 mg/kg) and dose 3-ethanolic extract of nardostachys jatamansi roots (400 mg/kg). The anti-convulsant activity was screened using maximal electroshock seizure model and pentylenetetrazole model. Results were analysed by ANOVA followed by post hoc Fisher’s LSD test.

Results: The ethanolic extract of nardostachys jatamansi roots at the dose of 400 mg/kg has shown significant anticonvulsant activity in maximal electroshock seizure (MES) model. Whereas, in pentylenetetrazole induced seizure model, the ethanolic extract of nardostachys jatamansi roots has shown significant anticonvulsant activity at the dose of 200 mg/kg and 400 mg/kg body weight.

Conclusions: The anticonvulsant activity of ethanolic extract of nardostachys jatamansi roots was less when compared to Sodium Valproate in Maximal Electro Shock model. Whereas, in Pentylenetetrazole induced seizure model, anticonvulsant activity of ethanolic extract of nardostachys jatamansi roots was comparable to sodium valproate.


Epilepsy, MES model, Nardostachys jatamansi, Pentylenetetrazole, Sodium valproate.

Full Text:



Acharya MM, Hattiangady B, Shetty AK. Progress in neuroprotective strategies for preventing epilepsy.Prog Neurobiol. 2008;84:363-404.

Saraf SA, Gupta R, Mishra A, Sharma AK, Punia RK. Advancements in traditional medicinal plants used in epilepsy. Phcog Rev. 2008;2:229-40.

Sander JWAS, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry. 1996;61:433-43.

Banerjee TK, Ray BK, Das SK, Hazra A, Ghosal MK, Chaudhuri A, et al. A longitudinal study of epilepsy in Kolkota, India. Epilepsia. 2010;51:2384-91.

Smith MC, Bleck TP. Convulsive disorders: toxicity of anticonvulsants. Clinical Neuropharmacology. 1991;14:97-115.

Mattson RH. Efficacy and adverse effects of established and new antiepileptic drugs. Epilepsia. 1995;36(2):13-26.

Smith M, Wilcox KS, White HS. White discovery of antiepileptic drugs. Neurotherapeutics. 2007;4:12-7.

De Smet P. The role of plant derived drugs and herbal medicines in healthcare. Drugs. 1997;54:801.

Schachter SC. Botanicals and herbs: a traditional approach to treating epilepsy. Neurotherapeutics. 2009;6:415-20.

Subashini R, Gnanapragasam A, Senthilkumar S, Yogeeta S, Devaki T. Protective effect of Nardostachys jatamansi (Rhizomes) on mitochondrial respiration and lysosomal hydrolases during doxorubicin induced myocardial injury in rats. J Health Sci. 2007;53:67-72.

Ali S, Ansari KA, Jafry MA, Kabeer H, Diwakar G. Nardostachys jatamansi protects against liver damage induced by thioacetamide in rats. J Ethnopharm 2000;71:359-63.

Ahmad M, Yousuf S, Khan MB, Hoda MN, Ahmad AS, Ansari MS, et al. Attenuation by nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies. Pharmacol Biochem Behav. 2006;83:150-60.

OECD (2000) guidance document on acute oral toxicity. Environmental health and safety monograph series on testing and assessment no 24.

James JEP, James EP, Grey ME. Anticonvulsants In evaluation of drug activities pharmacometrics. Volume I. Laurence DR, Bacharahah ARI (Eds.). London. Academic press; 1964:287.

Rao VS, Rao A, Karanth KS. Anticonvulsant and neurotoxicity profile of nardostachys jatamansi in rats. Journal of Ethanopharmacology. 2005;102:351-6.

Rücker G, Tautges J, Sieck A, Wenzl H, Graf E. Isolation and pharmacodynamic activity of the sesquiterpene valeranone from Nardostachys jatamansi DC (in German). Arzneimittel forschung. 1978;28:7-13.

Prabhu V, Karanth KS, Rao Al. Effects of nardostachys jatamansion biogenic amines and inhibitory amino acids in the rat brain. Planta Med. 1994;60:114-7.